Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
adjuvant treatment
early breast cancer
guideline
inflammatory breast cancer
locally advanced breast cancer
metastatic breast cancer
neoadjuvant treatment
Journal
Pathology oncology research : POR
ISSN: 1532-2807
Titre abrégé: Pathol Oncol Res
Pays: Switzerland
ID NLM: 9706087
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
02
2022
accepted:
29
04
2022
entrez:
28
7
2022
pubmed:
29
7
2022
medline:
30
7
2022
Statut:
epublish
Résumé
This text is based on the recommendations accepted by the 4th Hungarian Consensus Conference on Breast Cancer, modified based on the international consultation and conference within the frames of the Central-Eastern European Academy of Oncology. The professional guideline primarily reflects the resolutions and recommendations of the current ESMO, NCCN and ABC5, as well as that of the St. Gallen Consensus Conference statements. The recommendations cover classical prognostic factors and certain multigene tests, which play an important role in therapeutic decision-making. From a didactic point of view, the text first addresses early and then locally advanced breast cancer, followed by locoregionally recurrent and metastatic breast cancer. Within these, we discuss each group according to the available therapeutic options. At the end of the recommendations, we summarize the criteria for treatment in certain rare clinical situations.
Identifiants
pubmed: 35898593
doi: 10.3389/pore.2022.1610383
pii: 1610383
pmc: PMC9311257
doi:
Types de publication
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1610383Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2022 Rubovszky, Kocsis, Boér, Chilingirova, Dank, Kahán, Kaidarova, Kövér, Krakovská, Máhr, Mriňáková, Pikó, Božović-Spasojević and Horváth.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Sci Rep. 2015 Oct 27;5:15746
pubmed: 26503902
J Clin Oncol. 2010 Mar 1;28(7):1124-30
pubmed: 20124187
N Engl J Med. 2012 Feb 9;366(6):520-9
pubmed: 22149876
Cancer Med. 2016 Mar;5(3):389-97
pubmed: 26806010
Magy Onkol. 2016 Sep;60(3):241-57
pubmed: 27579723
N Engl J Med. 2020 Feb 13;382(7):610-621
pubmed: 31825192
J Clin Oncol. 2019 Aug 1;37(22):1868-1875
pubmed: 30939096
Oncologist. 2010;15(2):122-9
pubmed: 20156908
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
Cancer. 2007 Sep 1;110(5):965-72
pubmed: 17614302
JAMA Oncol. 2020 Jan 01;6(1):116-124
pubmed: 31563959
J Clin Oncol. 2012 Jul 20;30(21):2585-92
pubmed: 22689807
J Clin Oncol. 2020 Apr 20;38(12):1293-1303
pubmed: 31618131
Ann Oncol. 2019 Nov 1;30(11):1842
pubmed: 31407010
J Clin Oncol. 2016 Jul 1;34(19):2221-31
pubmed: 27044936
J Clin Oncol. 2003 Apr 15;21(8):1431-9
pubmed: 12668651
Lancet Oncol. 2012 Sep;13(9):869-78
pubmed: 22884505
Oncologist. 2020 Feb;25(2):e243-e251
pubmed: 32043763
N Engl J Med. 2016 Nov 3;375(18):1738-1748
pubmed: 27717303
Breast. 2017 Apr;32:112-118
pubmed: 28152498
Breast Cancer Res Treat. 2019 Jan;173(1):37-48
pubmed: 30267249
J Clin Oncol. 2017 Nov 10;35(32):3638-3646
pubmed: 28968163
Curr Treat Options Oncol. 2018 Apr 11;19(5):21
pubmed: 29644491
N Engl J Med. 2018 Nov 15;379(20):1926-1936
pubmed: 30345905
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
J Clin Oncol. 2010 Apr 20;28(12):2114-22
pubmed: 20308661
Lancet Oncol. 2014 Feb;15(2):156-63
pubmed: 24439313
J Clin Oncol. 2018 Oct 1;36(28):2826-2835
pubmed: 30106636
Breast Cancer Res Treat. 2013 Jan;137(2):465-70
pubmed: 23224235
N Engl J Med. 2021 Dec 16;385(25):2336-2347
pubmed: 34914339
Obstet Gynecol. 2008 Jul;112(1):71-8
pubmed: 18591310
Ann Oncol. 2022 Mar;33(3):321-329
pubmed: 34954044
Health Technol Assess. 2019 Jun;23(30):1-328
pubmed: 31264581
J Clin Oncol. 2006 Aug 10;24(23):3726-34
pubmed: 16720680
Ann Oncol. 2021 Aug;32(8):1015-1024
pubmed: 34102253
Crit Rev Oncol Hematol. 2010 Feb;73(2):141-55
pubmed: 19427229
Breast Cancer Res Treat. 2014 Sep;147(2):401-5
pubmed: 25129345
J Clin Endocrinol Metab. 2012 Apr;97(4):1159-68
pubmed: 22344196
J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8
pubmed: 18812550
J Clin Oncol. 2021 Jan 1;39(1):79-89
pubmed: 32822287
Ann Oncol. 2007 Jul;18(7):1133-44
pubmed: 17675394
Lancet Oncol. 2018 Jul;19(7):904-915
pubmed: 29804902
J Clin Oncol. 2013 Sep 10;31(26):3197-204
pubmed: 23940225
N Engl J Med. 2019 Jul 25;381(4):307-316
pubmed: 31166679
Lancet Oncol. 2014 Jun;15(7):689-99
pubmed: 24793816
Ann Oncol. 2017 Sep 01;28(9):2225-2232
pubmed: 28911092
Lancet. 2005 May 14-20;365(9472):1687-717
pubmed: 15894097
Ann Oncol. 2014 May;25(5):1004-11
pubmed: 24562447
N Engl J Med. 1996 May 23;334(21):1356-61
pubmed: 8614420
Lancet Oncol. 2020 Jan;21(1):44-59
pubmed: 31786121
Ann Oncol. 2016 Jun;27(6):1013-1019
pubmed: 26961146
Nat Med. 2018 May;24(5):628-637
pubmed: 29713086
Curr Oncol Rep. 2019 Feb 26;21(3):25
pubmed: 30806829
Ann Oncol. 2014 Dec;25(12):2357-2362
pubmed: 25231953
Breast. 2019 Aug;46:170-177
pubmed: 31226572
Ann Oncol. 2019 Oct 1;30(10):1541-1557
pubmed: 31373601
JAMA Oncol. 2018 Dec 1;4(12):1700-1706
pubmed: 30054636
Gland Surg. 2018 Oct;7(5):449-457
pubmed: 30505766
Breast Cancer Res Treat. 2016 Dec;160(3):501-509
pubmed: 27752847
Ann Oncol. 2013 Sep;24(9):2278-84
pubmed: 23704196
Eur J Cancer. 2018 Jan;89:27-35
pubmed: 29223479
N Engl J Med. 2018 Jul 12;379(2):111-121
pubmed: 29860917
J Clin Oncol. 2019 Feb 10;37(5):423-438
pubmed: 30452337
EPMA J. 2018 Jun 24;9(3):257-270
pubmed: 30174762
Lancet Oncol. 2011 Sep;12(9):852-61
pubmed: 21862407
Rheum Dis Clin North Am. 2017 Aug;43(3):489-502
pubmed: 28711148
J Clin Oncol. 2009 Nov 20;27(33):5529-37
pubmed: 19786670
Eur J Pharmacol. 2013 Oct 5;717(1-3):71-83
pubmed: 23545364
Ann Oncol. 2014 Jun;25(6):1079-85
pubmed: 24625452
Lancet Oncol. 2017 Dec;18(12):1688-1700
pubmed: 29146401
N Engl J Med. 2008 Apr 17;358(16):1663-71
pubmed: 18420499
J Clin Oncol. 2012 Aug 1;30(22):2718-24
pubmed: 22565002
Clin Breast Cancer. 2022 Jan;22(1):e74-e79
pubmed: 34690081
Histopathology. 2016 Jan;68(1):110-8
pubmed: 26768033
Clin Cancer Res. 2017 Sep 1;23(17):5218-5224
pubmed: 28533223
Ann Oncol. 2011 Mar;22(3):515-523
pubmed: 20603440
J Natl Cancer Inst Monogr. 2001;(30):62-6
pubmed: 11773294
Nat Rev Clin Oncol. 2015 Jan;12(1):27-41
pubmed: 25286972
PLoS One. 2017 Mar 15;12(3):e0173693
pubmed: 28296916
J Clin Oncol. 2009 Mar 10;27(8):1177-83
pubmed: 19204201
BMJ Open. 2015 Jan 27;5(1):e005576
pubmed: 25628047
Lancet Oncol. 2017 Jun;18(6):743-754
pubmed: 28526538
Future Oncol. 2021 Dec;17(34):4665-4676
pubmed: 34636255
N Engl J Med. 2017 Jul 13;377(2):122-131
pubmed: 28581356
Lancet. 2013 Mar 9;381(9869):805-16
pubmed: 23219286
Lancet Oncol. 2016 Jun;17(6):791-800
pubmed: 27179402
Ann Oncol. 2020 Dec;31(12):1623-1649
pubmed: 32979513
Eur J Cancer. 2012 Jan;48(1):24-9
pubmed: 21775129
Lancet Oncol. 2012 Jan;13(1):25-32
pubmed: 22153890
Lancet Oncol. 2013 Jan;14(1):72-80
pubmed: 23246022
Lancet Oncol. 2020 Jan;21(1):60-72
pubmed: 31806543
Ann Oncol. 2020 Dec;31(12):1650-1663
pubmed: 32801018
Breast Cancer Res. 2017 May 22;19(1):58
pubmed: 28532503
Menopause. 2016 Nov;23(11):1228-1232
pubmed: 27433858
J Bone Oncol. 2017 Mar 23;7:1-12
pubmed: 28413771
N Engl J Med. 2019 Feb 14;380(7):617-628
pubmed: 30516102
Breast Cancer Res. 2010;12(1):R1
pubmed: 20053270
Ann Surg Oncol. 2018 Oct;25(11):3158-3164
pubmed: 30094484
N Engl J Med. 2012 Aug 2;367(5):435-44
pubmed: 22853014
Ann Oncol. 2021 Dec;32(12):1571-1581
pubmed: 34656740
Ann Oncol. 2021 Aug;32(8):983-993
pubmed: 34272041
J Clin Oncol. 2007 Aug 1;25(22):3246-50
pubmed: 17577021
PLoS One. 2013 Oct 23;8(10):e78299
pubmed: 24194916
Lancet Oncol. 2016 Apr;17(4):425-439
pubmed: 26947331
Breast Cancer Res Treat. 2016 Jul;158(1):91-97
pubmed: 27306421
N Engl J Med. 2020 Feb 6;382(6):514-524
pubmed: 31826360
N Engl J Med. 2006 Dec 28;355(26):2733-43
pubmed: 17192538
Lancet Oncol. 2021 Apr;22(4):499-511
pubmed: 33676601
Lancet. 2016 Feb 27;387(10021):849-56
pubmed: 26686957
J Clin Oncol. 2007 Sep 1;25(25):3853-8
pubmed: 17679724
N Engl J Med. 2016 Nov 17;375(20):1925-1936
pubmed: 27959613
Oncologist. 2010;15(9):924-34
pubmed: 20736298
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD003370
pubmed: 19821307
Eur J Cancer. 2013 Nov;49(17):3579-87
pubmed: 23968730
Lancet. 2012 Feb 18;379(9816):633-40
pubmed: 22257673
JAMA Oncol. 2015 Oct;1(7):888-96
pubmed: 26291673
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
Ann Oncol. 2018 Feb 1;29(2):405-417
pubmed: 29092024
N Engl J Med. 2015 Feb 19;372(8):724-34
pubmed: 25693012
Breast Cancer Res Treat. 2019 Jul;176(1):227-234
pubmed: 30977027
Lancet Oncol. 2017 Jun;18(6):732-742
pubmed: 28526536
Lancet. 2015 Oct 3;386(10001):1353-1361
pubmed: 26211824
N Engl J Med. 2015 Jul 16;373(3):209-19
pubmed: 26030518
N Engl J Med. 2012 Nov 8;367(19):1783-91
pubmed: 23020162
J Natl Cancer Inst. 2020 Jul 1;112(7):659-660
pubmed: 31693134
Curr Treat Options Oncol. 2018 Apr 27;19(5):26
pubmed: 29704066
Ann Oncol. 2021 Aug;32(8):994-1004
pubmed: 34219000
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD005212
pubmed: 23633328
N Engl J Med. 2020 Feb 13;382(7):597-609
pubmed: 31825569
JAMA Netw Open. 2020 Jan 3;3(1):e1918176
pubmed: 31899524
Br J Cancer. 2012 Aug 21;107(5):800-7
pubmed: 22850554
Syst Rev. 2018 Sep 15;7(1):142
pubmed: 30219092
Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:46-51
pubmed: 29245056
Pathol Oncol Res. 2008 Jun;14(2):113-5
pubmed: 18543079
Breast Cancer Res Treat. 2018 Feb;168(1):127-134
pubmed: 29164421
J Cancer. 2018 Apr 6;9(8):1437-1447
pubmed: 29721054
Ann Oncol. 2019 Aug 1;30(8):1194-1220
pubmed: 31161190
N Engl J Med. 2017 Jun 1;376(22):2147-2159
pubmed: 28564564
Breast Cancer Res Treat. 2014 Jan;143(2):325-32
pubmed: 24327334
Ann Surg Oncol. 2018 Jul;25(7):1783-1785
pubmed: 29671136
BMC Cancer. 2019 Mar 14;19(1):230
pubmed: 30871490
Cochrane Database Syst Rev. 2019 Mar 03;3:CD008018
pubmed: 30827035
J Clin Oncol. 2020 Dec 1;38(34):3987-3998
pubmed: 32954927
Hong Kong Med J. 2017 Aug;23(4):387-94
pubmed: 28649094
J Clin Oncol. 2009 Nov 20;27(33):5538-46
pubmed: 19786658
J Clin Oncol. 2010 Jun 1;28(16):2784-95
pubmed: 20404251
J Clin Oncol. 2018 Aug 20;36(24):2465-2472
pubmed: 29860922
N Engl J Med. 2021 Jun 24;384(25):2394-2405
pubmed: 34081848
J Clin Oncol. 2018 May 10;36(14):1396-1404
pubmed: 29584547
Breast. 2012 Feb;21(1):27-33
pubmed: 21862331
N Engl J Med. 2018 Jul 12;379(2):122-137
pubmed: 29863451
Expert Opin Biol Ther. 2021 Feb;21(2):127-133
pubmed: 33238772
J Clin Oncol. 2017 Sep 1;35(25):2875-2884
pubmed: 28580882
J Clin Oncol. 2006 Jun 20;24(18):2786-92
pubmed: 16782917
J Clin Oncol. 2020 Sep 20;38(27):3138-3149
pubmed: 32678716